Total Payments
$191,160
2024 Payments
$898.99
Companies
19
Transactions
374
Medicare Patients
6,117
Medicare Billing
$7.5M
Payment Breakdown by Category
Other$125,525 (65.7%)
Consulting$50,375 (26.4%)
Food & Beverage$9,393 (4.9%)
Travel$5,218 (2.7%)
Education$648.91 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125,525 | 71 | 65.7% |
| Consulting Fee | $50,375 | 10 | 26.4% |
| Food and Beverage | $9,393 | 236 | 4.9% |
| Travel and Lodging | $5,218 | 17 | 2.7% |
| Education | $648.91 | 39 | 0.3% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$191,160
373 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $78,491 | 66 | $0 (2021) |
| Amgen Inc. | $59,991 | 179 | $0 (2024) |
| United Rheumatology | $43,279 | 8 | $0 (2021) |
| Janssen Biotech, Inc. | $6,384 | 30 | $0 (2024) |
| UCB, Inc. | $533.09 | 5 | $0 (2024) |
| ABBVIE INC. | $521.45 | 19 | $0 (2024) |
| DePuy Synthes Sales Inc. | $360.87 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $358.97 | 22 | $0 (2024) |
| Johnson & Johnson Health Care Systems Inc. | $335.89 | 5 | $0 (2022) |
| PFIZER INC. | $279.78 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $898.99 | 18 | Amgen Inc. ($376.94) |
| 2023 | $1,563 | 53 | Amgen Inc. ($645.55) |
| 2022 | $771.34 | 24 | Janssen Biotech, Inc. ($136.04) |
| 2021 | $24,339 | 43 | Janssen Scientific Affairs, LLC ($11,156) |
| 2020 | $32,611 | 30 | United Rheumatology ($17,500) |
| 2019 | $55,769 | 87 | Amgen Inc. ($24,644) |
| 2018 | $44,679 | 71 | Janssen Scientific Affairs, LLC ($21,807) |
| 2017 | $30,529 | 48 | Janssen Scientific Affairs, LLC ($14,312) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $38.85 | General |
| Category: Inflammation | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $113.24 | General |
| 11/16/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $101.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: Dermatology | ||||||
| 05/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: Dermatology | ||||||
| 05/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $123.03 | General |
| Category: Bone Health | ||||||
| 04/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: Dermatology | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Dermatology | ||||||
| 03/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Dermatology | ||||||
| 02/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: IMMUNOLOGY | ||||||
| 02/13/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $120.00 | General |
| 01/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: Dermatology | ||||||
| 12/08/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $131.32 | General |
| Category: Immunology | ||||||
| 11/11/2023 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 11/11/2023 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 10/04/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: KRYSTEXXA | ||||||
| 09/09/2023 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Rheumatology | ||||||
| 09/08/2023 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 980 | 57,049 | $2.4M | $981,824 |
| 2022 | 21 | 1,456 | 67,359 | $3.4M | $1.3M |
| 2021 | 22 | 1,413 | 53,844 | $3.5M | $1.5M |
| 2020 | 24 | 2,268 | 139,568 | $7.8M | $3.7M |
Total Patients
6,117
Total Services
317,820
Medicare Billing
$7.5M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 27 | 10,800 | $921,348 | $353,761 | 38.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 147 | 10,620 | $320,405 | $195,120 | 60.9% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 32 | 18,400 | $500,112 | $194,739 | 38.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 21 | 15,390 | $208,227 | $114,463 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 475 | $168,885 | $46,428 | 27.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 77 | 340 | $138,040 | $39,982 | 29.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 156 | 295 | $66,007 | $18,288 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 118 | $29,854 | $8,024 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $10,603 | $3,132 | 29.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 55 | $11,000 | $2,920 | 26.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 142 | $5,822 | $1,696 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 115 | 195 | $1,463 | $1,426 | 97.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 15 | $3,477 | $937.41 | 27.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 33 | $2,805 | $841.48 | 30.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 68 | $184.96 | $58.46 | 31.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 80 | $16.80 | $7.76 | 46.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 29 | 13,550 | $1.2M | $462,100 | 40.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 209 | 16,380 | $494,185 | $277,580 | 56.2% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 33 | 21,700 | $589,806 | $253,271 | 42.9% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 34 | 4,350 | $521,391 | $126,235 | 24.2% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 18 | 8,670 | $117,305 | $62,880 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 576 | $205,329 | $58,990 | 28.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 78 | 230 | $94,054 | $28,428 | 30.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 71 | 282 | $57,024 | $17,004 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 224 | $56,696 | $15,733 | 27.7% |
About Dr. Gary Feldman, MD
Dr. Gary Feldman, MD is a Rheumatology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841220373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Feldman, MD has received a total of $191,160 in payments from pharmaceutical and medical device companies, with $898.99 received in 2024. These payments were reported across 374 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($125,525).
As a Medicare-enrolled provider, Feldman has provided services to 6,117 Medicare beneficiaries, totaling 317,820 services with total Medicare billing of $7.5M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Los Angeles, CA
- Active Since 07/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1841220373
Products in Payments
- STELARA (Biological) $45,241
- Prolia (Biological) $42,871
- SIMPONI ARIA (Biological) $32,651
- EVENITY (Biological) $12,973
- TREMFYA (Drug) $3,541
- Enbrel (Biological) $424.80
- RINVOQ (Biological) $341.36
- XELJANZ (Drug) $279.78
- MONOVISC (Device) $226.70
- COSENTYX (Biological) $225.78
- KEVZARA (Biological) $193.41
- COSENTYX (Drug) $133.19
- Bimzelx (Biological) $131.32
- Rinvoq (Biological) $121.73
- MODICON (Drug) $103.82
- UPLIZNA (Biological) $101.82
- KEVZARA (Drug) $96.58
- KRYSTEXXA (Biological) $80.89
- DISEASE STATE (Drug) $64.28
- ORENCIA (Biological) $63.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Los Angeles
Dr. Glenn Ehresmann, M.d, M.D
Rheumatology — Payments: $770,098
Rheumatology $770,098
Dr. Daniel Arkfeld, M.d, M.D
Rheumatology — Payments: $570,588
Rheumatology $570,588
Maureen Mcmahon, Md, MD
Rheumatology — Payments: $327,802
Rheumatology $327,802
Jon Giles, M.d, M.D
Rheumatology — Payments: $285,629
Rheumatology $285,629
Christina Charles-Schoeman, Md, MD
Rheumatology — Payments: $281,888
Rheumatology $281,888
Thomas Romano, M.d, M.D
Rheumatology — Payments: $230,456
Rheumatology $230,456